A panel of independent health advisers convened Tuesday to consider a landmark proposal to approve MDMA as a treatment for post-traumatic stress disorder. In the end, Lykos’ MDMA drug approval proposal to treat PTSD failed with a 1-10 vote, reducing the chance for federal approval later this summer. The Psychopharmacologic …
Tag: reMind
The Daily Hit: June 3, 2024
The Daily Hit is a recap of the top financial news stories for Monday, June 3, 2024. On the Site Rescheduling, 280E tax reform, and Trulieve: How the cannabis industry could be poised to save billions Although it’s now widely accepted that the ongoing marijuana rescheduling process by the Drug …
Federal health agency acknowledges potential medical benefits of psilocybin in new PSA webpage
A new webpage apparently posted within the past week by a federal U.S. health agency acknowledges that psilocybin may have medical value, particularly for treating depression, despite its current status as a federally banned Schedule I drug. The page, “Psilocybin for Mental Health and Addiction: What You Need to Know,” …
Alaska to create task force to prepare state for MDMA therapy
The Alaska legislature passed a bill to establish a task force that will help prepare the state for potential federal legalization of psychedelic therapies, officials said. The task force won’t take a stance on whether psychedelic treatments are beneficial, said Rep. Jennie Armstrong, an Anchorage Democrat who introduced the House …